Related Experiment Videos
Substance abuse in borderline personality disorder
F T Miller1, T Abrams, R Dulit
1Cornell University Medical College, New York, New York.
The American Journal of Drug and Alcohol Abuse
|January 1, 1993
Summary
Substance abuse is common in borderline personality disorder (BPD) patients, often leading to poor life outcomes. Stimulant use in BPD patients was linked to fewer depersonalization-derealization symptoms.
Area of Science:
- Psychiatry
- Addiction Medicine
- Personality Disorders
Background:
- Borderline personality disorder (BPD) is a complex mental health condition.
- Co-occurring substance abuse is a significant clinical challenge in BPD.
- Understanding the interplay between BPD and substance use is crucial for effective treatment.
Purpose of the Study:
- To investigate the prevalence and patterns of substance abuse among patients with BPD.
- To explore the association between substance abuse and demographic/clinical factors in BPD.
- To examine the relationship between substance use and specific symptoms like depersonalization-derealization.
Main Methods:
- Retrospective analysis of patient data.
- Categorization of substance abuse types (alcohol/sedatives vs. stimulants).
- Comparison of clinical characteristics and symptom presentation across substance use groups.
Main Results:
- Substance abuse was highly prevalent in the studied BPD population.
- Gender differences in substance preference were observed: females favored alcohol/sedatives, males favored stimulants.
- Substance abuse correlated with adverse outcomes including poor school performance, unemployment, and promiscuity.
- Depersonalization-derealization symptoms were less frequent in stimulant users compared to non-users and alcohol/sedative users.
Conclusions:
- Substance abuse represents a severe complication for individuals with borderline personality disorder.
- Specific substance use patterns may be associated with distinct symptom profiles in BPD.
- Targeted interventions addressing substance abuse are essential for improving outcomes in BPD patients.